Clinical Trial Update: Effect of Ocrelizumab on Cortical Lesion Accumulation in Patients With PPMS (ORATORIO-Cortical)

View source ↗

Summary

The ORATORIO-Cortical clinical trial update reports on the effect of ocrelizumab on cortical lesion accumulation in patients with primary progressive multiple s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Primary Progressive Multiple Sclerosis | Status: COMPLETED